A glaucoma attack, known medically as acute angle-closure glaucoma, is a sudden spike in eye pressure that can permanently damage your vision within hours if left untreated. It happens when the drainage channel inside the eye gets physically blocked, trapping fluid and sending pressure soaring to dangerous levels. Unlike the more common open-angle glaucoma, which develops gradually over years with few noticeable symptoms, an acute attack hits fast, hurts, and demands a trip to the emergency room.
How to Recognize the Symptoms
The symptoms of a glaucoma attack can be confusing because they don’t always feel like an “eye problem.” Yes, the affected eye typically turns red and your vision blurs or dims, but you may also get a severe headache, nausea, and vomiting. Some people assume they’re having a migraine or a stomach bug and delay seeking care. The combination of a painful red eye, blurred vision, and nausea together should raise an immediate red flag.
During an attack, eye pressure can climb above 40 mmHg, sometimes reaching 50 or higher. Normal eye pressure runs roughly 10 to 21 mmHg. At those extreme levels, blood flow to the optic nerve and other delicate structures gets choked off, and the cornea may swell enough to produce halo effects around lights.1Korean Journal of Ophthalmology. Comparison of Glaucomatous Optic Nerve Damage in Primary Angle-Closure Glaucoma with and without Acute Attack One useful clue even before reaching a doctor: if you gently press on both closed eyelids, the affected eye often feels noticeably harder than the other, like pressing on a marble rather than a grape.2PubMed Central. Acute Closed-Angle Glaucoma-an Ophthalmological Emergency
What Happens Inside the Eye
To understand why an attack occurs, it helps to know that the eye constantly produces a clear fluid called aqueous humor. This fluid nourishes the front of the eye and then drains out through a tiny channel located at the angle where the iris meets the cornea. In most people this drainage angle is wide open, and fluid flows out easily. In people prone to angle closure, the anatomy is tighter: the iris sits closer to the lens and closer to the drainage channel, leaving less room for fluid to circulate.
The most common trigger for an acute attack is something called pupillary block. The back surface of the iris presses against the lens just tightly enough to obstruct the normal flow of fluid from behind the iris to in front of it. Pressure builds behind the iris, bowing it forward like a sail catching wind, and this forward bulge slams the drainage angle shut.3JAMA Ophthalmology. Pupillary Block, Angle-closure Glaucoma Produced by an Anterior Chamber Air Bubble in a Nanophthalmic Eye Once the angle is closed, pressure climbs rapidly.
Not every attack follows this pathway, though. Some medications, particularly sulfa-based drugs like topiramate, cause swelling of the ciliary body, a ring of tissue behind the iris. That swelling pushes the iris-lens unit forward, closing the angle through a completely different mechanism that has nothing to do with pupillary block.4Latin American Journal of Ophthalmology. Topiramate-induced acute angle-closure glaucoma: A case report and review of literature This distinction matters because the standard laser treatment for pupillary block won’t help in a drug-induced case driven by ciliary body swelling.
Who Is Most at Risk
Certain eye anatomy makes an attack far more likely. People with a shallow front chamber of the eye, a shorter-than-average eyeball, or a thicker, more forward-positioned lens are the classic candidates.5PubMed Central. Drug-induced Acute Angle-closure Glaucoma: A Review 6Ophthalmology. Ophthalmic Technology Assessment Evaluation of the Anterior Chamber Angle in Glaucoma: A Report by the American Academy of Ophthalmology These anatomical features tend to cluster together, and they’re often present in people who are farsighted, since farsighted eyes tend to be shorter. Women are affected more often than men, and the risk increases with age as the lens thickens naturally over time.
Ethnicity plays a role as well. Research consistently shows that angle-closure glaucoma is more common in people of East Asian descent and among Inuit populations, while it’s less common in people of European or African descent.7PubMed. Ethnic differences in primary angle-closure glaucoma The incidence in European populations runs around 2 to 4 cases per 100,000 people per year.2PubMed Central. Acute Closed-Angle Glaucoma-an Ophthalmological Emergency That sounds rare, but for those affected the consequences can be severe, and people with the predisposing anatomy may not know they’re at risk until an attack strikes.
Medications and Other Triggers
A long list of medications can nudge a susceptible eye into crisis. Drugs that dilate the pupil are the most obvious culprits, since a mid-dilated pupil is the position where pupillary block is most likely to occur. But the range of drugs implicated goes well beyond eye drops. Antidepressants, antihistamines, decongestants, certain migraine medications, and even some anti-seizure drugs have all been linked to acute angle closure.8PubMed Central. A review of drug-induced acute angle closure glaucoma for non-ophthalmologists
A large pharmacovigilance study identified 61 drugs significantly associated with acute angle closure. The migraine drug sumatriptan carried the highest odds, followed by topiramate and the antidepressant duloxetine.9JAMA Ophthalmology. Association of Drugs With Acute Angle Closure If you have narrow drainage angles or other risk factors, it’s worth flagging this with every prescribing doctor, not just your eye specialist. Many of these drugs are prescribed by primary care physicians, neurologists, or psychiatrists who may not think to ask about your eye anatomy.
Dim lighting and emotional stress can also play a role, since both cause the pupil to dilate naturally. Some attacks start in movie theaters, during evening drives, or after episodes of intense anxiety. These triggers don’t cause a problem in healthy eyes, but in eyes already teetering on the edge anatomically, a slight pupil change can be the final push.
What to Do If You Suspect an Attack
Go to the emergency room. This is not a “call your eye doctor on Monday” situation. Every hour of sustained high pressure increases the risk of permanent optic nerve damage, so treatment needs to start within hours, ideally sooner. If an ophthalmologist is not immediately available at the ER, the emergency team can begin pressure-lowering medications while arranging a specialist consultation.
The initial treatment usually involves several approaches at once. You’ll likely receive eye drops that constrict the pupil, pulling the iris away from the drainage angle to try to break the block. Oral or intravenous medications to rapidly reduce fluid production inside the eye are given alongside. The goal is to bring the pressure down from its dangerous peak as quickly as possible.10PubMed Central. Emergency management: angle-closure glaucoma
While waiting for care, there is essentially nothing effective you can do at home. Lying on your back in a bright room (bright light constricts the pupil) might offer a marginal theoretical benefit, but no home remedy substitutes for medication. If you’ve been prescribed pilocarpine drops in the past for a prior episode, using them is reasonable while heading to the hospital, but don’t delay the trip.
Definitive Treatment After the Acute Phase
Once the acute pressure spike has been controlled with medications, the next step is preventing it from happening again. The most common procedure is laser peripheral iridotomy, where the ophthalmologist uses a laser to create a tiny hole in the iris. This bypass allows fluid to flow through directly, equalizing pressure on both sides of the iris and preventing the forward bowing that causes pupillary block.
Laser iridotomy widens the drainage angle in all stages of angle closure and has a good safety profile.11PubMed. Laser Peripheral Iridotomy in Primary Angle Closure: A Report by the American Academy of Ophthalmology For many patients, particularly those caught early before chronic damage has set in, iridotomy is sufficient and no further surgery is needed. However, eyes that have already developed glaucomatous nerve damage often require additional treatment, such as ongoing pressure-lowering drops or more invasive surgery.
In cases where the pressure can’t be controlled with drops and iridotomy alone, or where a cataract is already present, removing the natural lens through cataract surgery (phacoemulsification) has become an increasingly favored option. A Cochrane review comparing lens extraction to laser iridotomy in acute angle closure found that lens removal resulted in better pressure control at 18 to 24 months and greatly reduced the need for further pressure-lowering surgery.12Cochrane Database of Systematic Reviews. Lens extraction versus laser peripheral iridotomy for acute primary angle closure Since the thickened natural lens is often a major contributor to the crowded anatomy, replacing it with a thin artificial lens physically opens up the drainage angle.
A small study of patients whose pressure couldn’t be controlled with conventional treatment found that cataract surgery brought average pressure down from roughly 35 mmHg before surgery to about 12 mmHg afterward, with all eyes achieving safe pressure levels.13Korean Journal of Ophthalmology. Cataract surgery in patients with acute primary angle-closure glaucoma The trade-off is that cataract surgery is a more involved procedure than a quick laser treatment, so it’s typically reserved for more complicated or refractory cases.
Long-Term Outlook
Even after an acute attack is resolved and follow-up treatment is performed, the long-term picture isn’t always reassuring. The damage done during the hours of high pressure can be permanent. In a study of Asian patients examined an average of about six years after their acute episode, roughly half had glaucomatous optic nerve damage in the affected eye, and about 18% were legally blind in that eye. Half of those blindness cases were directly caused by glaucoma.14PubMed. Long-term outcomes in asians after acute primary angle closure
Research in Caucasian patients shows a similar pattern of long-term structural and functional damage, with the attack eye showing significantly worse nerve damage and visual field loss compared to the fellow eye even years later.15PubMed. Long-term outcomes after acute primary angle closure of Caucasian chronic angle closure glaucoma patients These outcomes reinforce just how critical it is to treat the attack quickly. The difference between getting treated within a few hours versus waiting a day can mean the difference between keeping functional vision and losing it.
Protecting the Other Eye
If you’ve had an acute attack in one eye, the other eye almost certainly shares the same crowded anatomy and is at high risk for its own attack. Standard practice is to perform prophylactic laser iridotomy on the fellow eye as soon as possible, even if it feels perfectly fine. One study of an Asian population found that this preventive iridotomy was safe and kept eye pressure controlled in about 89% of fellow eyes over roughly four years of follow-up.16PubMed. Acute primary angle closure in an Asian population: long-term outcome of the fellow eye after prophylactic laser peripheral iridotomy
That said, prophylactic iridotomy doesn’t guarantee the fellow eye stays healthy. In one study of Caucasian patients, over half of fellow eyes went on to develop chronic angle closure despite having received prompt preventive iridotomy.15PubMed. Long-term outcomes after acute primary angle closure of Caucasian chronic angle closure glaucoma patients And roughly 7 to 9% of fellow eyes develop definite glaucoma over several years regardless.17Ophthalmology. Long-Term Outcomes of the Contralateral Eye in Asian Persons with Acute Primary Angle Closure This means ongoing monitoring of both eyes after an attack is essential, even after laser treatment.
There’s also a trade-off to prophylactic iridotomy that patients should know about: the procedure can accelerate cataract formation, particularly a type called posterior subcapsular cataract.18PubMed. Cataract progression after prophylactic laser peripheral iridotomy: potential implications for the prevention of glaucoma blindness For older adults who may already be developing cataracts, this can mean needing cataract surgery sooner than they otherwise would have. It’s still usually the right call, since an acute attack is far more damaging than a cataract, but it’s worth discussing with your ophthalmologist.
When You’re a “Suspect” but Haven’t Had an Attack
Many people learn they have narrow angles during a routine eye exam and are told they’re at risk for angle closure. This is the “primary angle-closure suspect” category. The question of whether these people should receive preventive laser iridotomy has been debated for years.
A large randomized trial found that the actual rate of angle-closure disease among people identified as suspects through community screening was very low, and that while prophylactic iridotomy did have a statistically significant protective effect, the overall benefit was limited because so few suspects ever progressed to an actual attack.19The Lancet. Laser peripheral iridotomy for the prevention of angle closure: a single-centre, randomised controlled trial The researchers concluded that widespread prophylactic iridotomy for all angle-closure suspects is not recommended.
This doesn’t mean you should ignore the finding. It means the decision should be individualized. If you’re a suspect and you’re about to start a medication known to trigger angle closure, or if your anatomy looks particularly tight on imaging, your ophthalmologist may lean toward preventive treatment. For others, careful monitoring with periodic angle assessments may be the more appropriate path. A cost-effectiveness analysis in Japan found that prophylactic iridotomy was cost-effective for middle-aged patients with suspicious angles, suggesting the calculus may shift depending on age and individual risk level.20PubMed Central. Cost-effectiveness analysis of prophylactic laser peripheral iridotomy for primary angle-closure suspect in Japan
Why Attacks Get Misdiagnosed
One of the most frustrating aspects of glaucoma attacks is how often they’re initially misdiagnosed. The headache, nausea, and vomiting can look like a migraine, a gastrointestinal illness, or even a stroke. Patients sometimes end up in the general medicine or neurology ward rather than seeing an eye specialist. This is especially true when the eye redness is mild or when the patient focuses on their headache rather than their vision changes when describing symptoms to the triage nurse.
The risk of misdiagnosis rises in older patients, who may attribute blurred vision to existing conditions and who are more likely to present with atypical symptoms. If you or someone you’re with has sudden severe eye pain with a headache and nausea, specifically mentioning the eye symptoms to the emergency team can speed up correct diagnosis. A doctor who thinks to check eye pressure, even by simply pressing gently on the eyeball through the lid, can often identify the problem quickly.
Imaging the Drainage Angle
Ophthalmologists have two main tools for examining the eye’s drainage angle in detail: ultrasound biomicroscopy and anterior segment optical coherence tomography (a type of light-based scan). Both can measure the angle’s width and identify anatomical features that increase risk.21PubMed Central. Anterior segment imaging in glaucoma: An updated review
While both technologies are useful, they don’t always agree on exact measurements. A comparative study found that measurements from the two devices were correlated but showed poor agreement with each other, meaning one can’t simply substitute for the other when precise measurements matter.22Eye. Prospective comparison of ultrasound biomicroscopy and anterior segment optical coherence tomography for evaluation of anterior chamber dimensions in European eyes with primary angle closure Ultrasound biomicroscopy requires a small probe touching the eye and can see behind the iris, while the light-based scan is non-contact and faster but can’t image structures hidden behind pigmented tissue. In practice, many clinics rely on the light-based scan for initial screening and reserve ultrasound for cases where the anatomy behind the iris needs a closer look, such as when a tumor or unusual iris configuration is suspected.
For patients, the practical takeaway is that if you’ve been told you have narrow angles based on one type of scan, asking your doctor whether additional imaging would change the management plan is a reasonable question, particularly if the decision about preventive treatment is on the fence.